ong-Term Follow-Up in Pediatric and Adolescent with Acute Lymphoblastic Leukemia receiving hospital-manufactured CAR-T
Not Applicable
Recruiting
- Conditions
- Neoplasms
- Registration Number
- KCT0009475
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Participants who were enrolled in advanced regenerative medicine clinical trials and received SNUH-CD19-CAR-T therapy
: This includes individuals who received SNUH-CD19-CAR-T treatment but, for any reason”, did not complete the planned schedule of the clinical trial.
Exclusion Criteria
Not Applicable
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method